AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ORNIDAZOLE

10 registrations across 4 African markets— 10 active

Markets with ORNIDAZOLE

Recent registrations

Brand / ProductMarketHolderStatusExpires
TIBERAL
COMPRIME ENROBE
🇲🇦Moroccoactive
ORNIDAZOLE
PARENTERAL ORDINARY INFUSION VIALS/BOTTLES
🇺🇬UgandaABACUS PARENTERAL DRUGS LIMITEDactive
ORNIDAZOLE
PARENTERAL ORDINARY INFUSION VIALS/BOTTLES
🇺🇬UgandaABACUS PARENTERAL DRUGS LIMITEDactive
ZINRO
Solution for injection
🇹🇿TanzaniaAbacus Parenteral Drugs Ltd (APDL)active
Dazolic
Tablets
🇹🇿TanzaniaSun Pharmaceutical Industries Ltdactive
TIBERAL 500MG COMPRIME BOITE DE 10🇨🇮Côte d'IvoireSERBactive
TIBERAL 500MG COMPRIME BOITE DE 3🇨🇮Côte d'IvoireSERBactive
TIBERAL
COMPRIME ENROBE
🇲🇦Moroccoactive
TIBERAL
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
Orgyl
Tablets
🇹🇿TanzaniaKusum Healthcare Pvt. Ltdactive

ORNIDAZOLE in Africa — Regulatory Overview

ORNIDAZOLE is registered across 4 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tanzania, Côte d'Ivoire, Uganda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.